Lead Product(s) : Clonixin Lysine
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : Pharmagenix
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 22, 2011
Lead Product(s) : Clonixin Lysine
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : Pharmagenix
Deal Size : Inapplicable
Deal Type : Inapplicable